Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort.
Journal: Therapeutic advances in medical oncology
Published: April 04, 2025
Olaparib monotherapy or in combination with abiraterone for treating mutated metastatic castration-resistant prostate cancer: alone or stronger together?
Journal: Expert opinion on investigational drugs
Published: August 13, 2024
Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 23, 2024
Intermittent Androgen Deprivation for Biochemically Recurrent Prostate Cancer: First Do No Harm.
Journal: European urology focus
Published: December 16, 2022
Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma.
Journal: Frontiers in oncology
Published: October 13, 2022
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors.
Journal: Molecular cancer research : MCR
Published: August 30, 2022
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 19, 2022
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature.
Journal: European urology oncology
Published: February 20, 2022
PARP Inhibition in Advanced Prostate Cancer.
Journal: Cancer journal (Sudbury, Mass.)
Published: December 14, 2021
A multicenter characterization of hepatitis associated with immune checkpoint inhibitors.
Journal: Oncoimmunology
Published: February 25, 2021
Last Updated: 09/26/2026